Nang Kuang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Nang Kuang Pharmaceutical has a total shareholder equity of NT$2.3B and total debt of NT$508.8M, which brings its debt-to-equity ratio to 21.8%. Its total assets and total liabilities are NT$3.5B and NT$1.2B respectively. Nang Kuang Pharmaceutical's EBIT is NT$205.3M making its interest coverage ratio 576.8. It has cash and short-term investments of NT$230.7M.
Key information
21.8%
Debt to equity ratio
NT$508.75m
Debt
| Interest coverage ratio | 576.8x |
| Cash | NT$230.69m |
| Equity | NT$2.33b |
| Total liabilities | NT$1.21b |
| Total assets | NT$3.54b |
Recent financial health updates
Recent updates
There May Be Some Bright Spots In Nang Kuang Pharmaceutical's (TWSE:1752) Earnings
Nov 19
Nang Kuang Pharmaceutical Co., Ltd.'s (TWSE:1752) 28% Price Boost Is Out Of Tune With Earnings
May 22Some Investors May Be Willing To Look Past Nang Kuang Pharmaceutical's (TWSE:1752) Soft Earnings
Apr 02Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet
Mar 20Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)
Mar 03Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?
Feb 13
Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years
Jan 26Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)
Jan 08Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend
Nov 29Financial Position Analysis
Short Term Liabilities: 1752's short term assets (NT$1.4B) exceed its short term liabilities (NT$1.1B).
Long Term Liabilities: 1752's short term assets (NT$1.4B) exceed its long term liabilities (NT$91.4M).
Debt to Equity History and Analysis
Debt Level: 1752's net debt to equity ratio (11.9%) is considered satisfactory.
Reducing Debt: 1752's debt to equity ratio has increased from 21.4% to 21.8% over the past 5 years.
Debt Coverage: 1752's debt is well covered by operating cash flow (85.9%).
Interest Coverage: 1752's interest payments on its debt are well covered by EBIT (576.8x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 20:30 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nang Kuang Pharmaceutical Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| Yuan Lu | KGI Securities Co. Ltd. |
| Xiaowei Huang | Masterlink Securities Corp. |